Results 81 to 90 of about 48,914 (162)

Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan. [PDF]

Breast Cancer (Dove Med Press)
Chen YC, Cheng MC, Chen PH, Chung CH, Chien WC, Dai MS, Chen JH, Huang TC.   +7 more
europepmc   +1 more source

Evaluation of Growth Differentiation Factor 15 as an Early Biomarker of Anthracycline-Induced Cardiotoxicity Using an Integrated PK/PD Model. [PDF]

Clin Transl Sci
Dabour MS, Blaes AH, Jacobson PA, Kirstein MN, Zordoky BN, Cheng S.   +5 more
europepmc   +1 more source

Early anthracycline cardiotoxicity in adolescents and young adults with sarcoma: a prospective echocardiographic study. [PDF]

ESC Heart Fail
Koutroumpakis E, Triantafyllou E, Livingston JA, Song J, Viguet C, Hughes A, Rauschendorfer SV, Jeyabal P, Honey TA, Chandra J, Daw NC, Hildebrandt MAT, Banchs J, Gilchrist SC, Roth ME, Deswal A, Kleinerman ES.   +16 more
europepmc   +1 more source

A multimodal approach to early detection of anthracycline-induced cardiotoxicity: complementary roles of left ventricular global longitudinal strain, left atrial reservoir strain, and high-sensitivity troponin I. [PDF]

J Cardiovasc Imaging
Kaya AF, Özbek M.
europepmc   +1 more source

Real-World Outcomes of Neoadjuvant Dual Blockade in HER2-Positive Breast Cancer: The Role of Tumor Biology and pCR. [PDF]

J Clin Med
Bayramgil A, Yücel MH, Turkoglu E, Guren AK, Kemik F, Ulufer B, Çakan Demirel B, Yildiz A, Sacli O, Ercin E, Demircan NC, Kinikoglu O, Lacin S, Bilici A, Altintas YE, Ozcelik M.   +15 more
europepmc   +1 more source

Correction: An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity

Frontiers in Pharmacology
Sicong Xie, Yuwei Sun, Xuan Zhao, Yiqun Xiao, Fei Zhou, Liang Lin, Wei Wang, Bin Lin, Zun Wang, Zixuan Fang, Lei Wang, Yang Zhang, Yang Zhang   +12 more
doaj   +1 more source

Methylated PIH1D1 as a Heart-Specific Biomarker for Anthracycline-Induced Cardiac Remodeling in Breast Cancer Patients. [PDF]

JACC Basic Transl Sci
Hsu PY, Huang WH, Lee YY, Passier R, Li SC, Hong CL, Hung SK, Lin HY, Lin CH, Chien CY, Li YD, Lee HC, Désaubry L, Nebigil CG, Chan MWY, Chan MWY.   +15 more
europepmc   +1 more source

Changes in circulating miR-199a, cardiac troponin I, NT-proBNP, and left ventricular ejection fraction during anthracycline therapy in breast cancer patients. [PDF]

Cardiooncology
Kamian S, Azadeh P, Anbiaee R, Mafi A, Ashoori H, Ghoshouni H, Bahadori MJ, Malakouti T.   +7 more
europepmc   +1 more source

Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group network. [PDF]

ESMO Open
Baldi GG, Frezza AM, Biagioni C, Benelli M, Bazzurri S, Cesari M, Bianchi G, Greto D, Campanacci DA, Aliberti S, Milano GM, Puma N, Vincenzi B, Brunello A, Asaftei SD, Kelaney RM, Gambarotti M, Collini P, Franchi A, Sbaraglia M, Dagrada GP, Morosi C, Gronchi A, Casali PG, Stacchiotti S.   +24 more
europepmc   +1 more source